The stock's fall snapped a two-day winning streak.

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

Shares of Quest Diagnostics Inc. DGX advanced 1.57% to $165.19 Monday, on what proved to be an all-around favorable trading ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by investment analysts at UBS Group from $166.00 ...

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...

NORTHAMPTON, MA / ACCESS Newswire / February 13, 2025 / I started as a Route Service Representative back in March 1984 at a small lab in Cambridge, Massachusetts called Spectrum Medical Labs as one of ...

The B.C. Government Employees Union, which represents about 1,200 LifeLabs workers in the province, issued 72-hour strike ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Sonora Quest Laboratories released a Thursday news release promoting a male fertility test men can buy online and take privately at home.

State of Alaska Department of Revenue reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 32.6 ...

Grail (GRAL) is rallying 15% and set a new all-time high after Quest Diagnostics (DGX) and GRAL announced earlier today that ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...